- Report
- September 2024
- 353 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 308 Pages
Global
From €2662EUR$2,800USD£2,236GBP
€3803EUR$4,000USD£3,195GBP
- Report
- May 2024
- 296 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP
- Report
- May 2024
- 313 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP
- Report
- April 2024
- 269 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP
- Report
- February 2025
- 262 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 149 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- April 2024
- 138 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- September 2024
- 187 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- September 2024
- 172 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Drug Pipelines
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP

The Coronavirus Diagnostics market is a rapidly growing sector of the healthcare industry. It is focused on the development and production of tests and other diagnostic tools to detect the presence of the virus. These tests are used to identify individuals who have been infected with the virus, as well as those who may have been exposed to it. Diagnostics are also used to monitor the spread of the virus and to track its mutations.
The market is composed of a variety of companies, ranging from large multinationals to small startups. These companies are developing a range of tests, from rapid antigen tests to more complex molecular tests. They are also developing technologies to improve the accuracy and speed of testing, as well as to reduce the cost of testing.
Some of the major players in the Coronavirus Diagnostics market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Roche Diagnostics, and Thermo Fisher Scientific. Other companies in the market include BioMedomics, BioFire Diagnostics, Luminex, and Quidel. Show Less Read more